Bristol-Myers Squibb (BMY) Tops Q3 EPS by 4c; Boosts FY15 EPS Outlook
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $62.62 --0%
EPS Growth %: +5.5%
Financial Fact:
Cost of products sold: 1.31B
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +5.5%
Financial Fact:
Cost of products sold: 1.31B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $4.07 billion versus the consensus estimate of $3.83 billion.
Guidance:
Bristol-Myers Squibb sees FY2015 EPS of $1.85-$1.90, versus the consensus of $1.84.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- FactSet acquires BCC Group to expand real-time market data platform
- Canaccord Reiterates Hold Rating on Yeti Holdings Inc. (YETI)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Trader TalkRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
